-
Bristol Myers to build first cell therapy factory in Europe — Teva CEO Schultz sees a 35% raise despite company's legal woes — Why Biogen Q1 earnings weren't good enoughSee more on our front page news Stay updated with the latest pharma-related coronavirus news on our new pageDismiss Notice
J & J Pension Question
Discussion in 'Johnson & Johnson' started by anonymous, Jun 4, 2020 at 10:59 AM.
Tags:
Add Tags